U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Variance from Manufacturer Report Number Format - No. 5
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Variance from Manufacturer Report Number Format - No. 5 August 1996

Final
Docket Number:
FDA-2020-D-0957
Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health
DATE: August 12, 1996
TO: Medical Device Manufacturers
FROM: Deputy Director, Office of Surveillance and Biometrics
Center for Devices and Radiological Health, FDA
SUBJECT: VARIANCE FROM MANUFACTURER REPORT NUMBER FORMAT


The Office of Surveillance and Biometrics, CDRH, has received several requests from manufacturers to add a new variance which would authorize a firm to use the Facility Registration Number of the reporting site in place of the Facility Registration Number of the manufacturing site of an affected device. Therefore, under the authority of 21 CFR Part 803.19(c), the following variance may be used by manufacturers when filling out form 3500A for reportable adverse medical device reports (MDRs):
 

VARIANCE NO. 5 (V1996005): Manufacturers who have one or more reporting site locations may use the Facility Registration Number of those sites in place of the Facility Registration Number of the manufacturing site of the affected device. In this case, the manufacturer report number requested on MedWatch form 3500A will consist of the reporting site facility registration number, the 4-digit calendar year in which the report was submitted and a 5-digit sequence number. In order to take advantage of this variance, the registration number and address of the manufacturing site of the affected device must be listed in Block G1 of the form.
 

If you have any questions regarding this variance, please contact the Reporting Systems Monitoring Team at: (301) 594-2735, Fax no. (301) 827-0038 or write to:
 

Reporting Systems Monitoring Team, HFZ-533
Division of Surveillance Systems
Office of Surveillance and Biometrics
1350 Piccard Drive
Rockville, MD 20850

Email: rsmb@cdrh.fda.gov


 

Susan N. Gardner, Ph.D.

 

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2020-D-0957.

Back to Top